Table 6.
Sample data | Results | ||
---|---|---|---|
Fold change | |||
ID | P53 |
bcl2 |
Casp3 |
Cont. HeLa | 1 | 1 | 1 |
Paclitaxel | 3.73 ± 0.14 | 0.38 ± 0.14 | 4.06 ± 0.1 |
Carboplatin | 7.08 ± 0.22 | 0.24 ± .005 | 8.59 ± 0.25 |
Gallic acid | 8.59 ± 0.25 | 0.28 ± 0.07 | 6.29 ± 0.27 |
Mix. 1 | 22.56 ± 1.58 | 0.28 ± 0.06 | 19.31 ± 0.61 |
Mix. 2 | 16.73 ± 0.81 | 0.28 ± 0.02 | 21.33 ± 0.95 |
Mix. 3 | 10.68 ± 68 | 0.22 ± 0.01 | 7.68 ± 0.23 |
Mix. 4 | 13.62 ± 0.96 | 0.31 ± 0.02 | 16.22 ± 1.01 |
The results were represented as mean of fold changes (2^ΔΔCT) ± SD. β-actin gene was used as a control gene